Trial intelligence / Profile preview

Evaluation of Renal Function in Patients with Atrial Fibrillation Receiving Warfarin vs Aspirin

TCTR20240509001Completed

Sponsor
N/A
Start
Aug 2023
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label trial of warfarin and aspirin in Atrial fibrillation (AFib) (2 arms), sponsored by N/A. Primary endpoint: Renal function parameters. Started Aug 2023; status: completed.

02

Drugs

warfarinaspirin
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on TCTR20240509001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240509001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call